Results 251 to 260 of about 34,959 (356)

Unveiling the nexus between direct-acting antivirals in hepatitis C virus elimination and immune response. [PDF]

Clin Exp Med
Abdelaziz AI, Abdelsameea E, Wahdan SA, Elsherbiny D, Zakaria Z, Azab SS.   +5 more
europepmc   +1 more source

From Food Waste to Valorized Nanomaterials: Sustainable Green Synthesis and Biomedical Applications

ChemFoodChem, EarlyView.
Food waste‐derived biomolecules act as natural reducing and stabilizing agents for the green synthesis of functional NPs with applications in antimicrobial systems, food packaging, biomedical technologies, and environmental remediation. ABSTRACT Food waste is a global issue, with billions of tons discarded and unutilized annually, causing economic ...
Siddhraj Rajput, Gautam Priyadarshi, Santosh Kumar Sahu, Bhakti Patel, Avni Thakker, Sherzodbek Tashbaev, Gulomov Gafurjon Shavkatbek Ugli, Dipak Kumar Sahoo, Ashish Patel   +8 more
wiley   +1 more source

Evaluation of hyaluronic acid and type III procollagen peptide as predictors for treatment response to direct-acting antivirals. [PDF]

World J Virol
Abdelrazek MA, Elghwab AI, Tabll AA, Elsayed EH, El Behery M.   +4 more
europepmc   +1 more source

Changes in Three-Dimensional Volumetric Liver Fat Fraction after Cure of Chronic Hepatitis C Infection with Direct-Acting Antivirals

Jessie Torgersen, Craig Newcomb, Dean M Carbonari, Shanae M Smith, Katherine L Brecker, Chamith S. Rajapakse, Brandon C. Jones, Christiana Cottrell, Rasleen Grewal, Jennifer C Price, Joshua F Baker, Jay R. Kostman, Stacey Trooskin, Rebecca A Hubbard, B. Zemel, Mary B. Leonard, Vincent Lo Re   +16 more
openalex   +1 more source

Direct-acting Antivirals in Kidney Transplant Patients: Successful Hepatitis C Treatment and Short Term Reduction in Urinary Protein/Creatinine Ratios

, 2017
Michael R. Goetsch, Ashutosh Tamhane, Mohit Varshney, Anuj Kapil, Edgar T. Overton, Graham C. Towns, Ricardo Franco   +6 more
openalex   +2 more sources

Living Microbial Drugs

Chemistry – A European Journal, EarlyView.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik, Nazlıcan Tunç, Senem Şen, Urartu Özgür Şafak Şeker   +3 more
wiley   +1 more source

Inpatient hospital burden of hepatitis C-diagnosed patients with decompensated cirrhosis [PDF]

, 2018
Cheung, Costella, D'Amico, Davis, Deuffic-Burban, el-Serag, European Association for Study of Liver, European Association for the Study of the Liver, Fattovich, Foster, Health Protection Scotland, Innes, Innes, Ioannou, Kendrick, Liu, Martin, McAdam-Marx, McDonald, Petta, R Development Core Team, Santen, Scott, Shaw, Wright, Wright   +25 more
core   +2 more sources

Direct-Acting Antivirals and Risk of Hepatitis C Extrahepatic Manifestations.

JAMA Netw Open
Jeong D, Wong S, Karim ME, Manges AR, Makuza JD, Velásquez García HA, Adu PA, Binka M, Yu A, Bartlett SR, Krajden M, Janjua NZ.   +11 more
europepmc   +1 more source

Post-treatment life-trajectories among people who inject drugs who completed hepatitis C treatment with direct acting antivirals: A thematic analysis. [PDF]

Br J Health Psychol
Vojt G, Elliott L, Family H, Sharkey C, Stephens B, Hutchinson S, Hickman M, Dillon JF, Harris M, Flowers P.   +9 more
europepmc   +1 more source

ProTides for Antiviral Activity Beyond Liver Cells

Chemistry – A European Journal, EarlyView.
A strategy for obtaining prodrugs of antiviral nucleotides with broad tissue activity is presented that relies on cycloalkyl or cycloalkylalkyl esters, improving uptake and esterase cleavage, and producing nanomolar inhibitors in kidney, colon, and lung cells.
Felix Goebel, Adrian Humboldt, Heeyoung Kim, Carl J. M. Schölzel, Ralf Bartenschlager, Clemens Richert   +5 more
wiley   +1 more source